Forecast: Basic Pharmaceutical Products Turnover in Poland

Analysis of the turnover for basic pharmaceutical products in Poland shows significant fluctuations from 2013 to 2023, with values peaking at 209.6 million euros in 2016, followed by a drastic decline to 93.1 million euros in 2017. The turnover slightly rebounded to 138.0 million euros in 2020 but has since experienced a downward trend, with the value at 104.9 million euros in 2023.

Year-on-year variations for 2022 and 2023 indicated negative growth rates of -4.45% and -4.11%, respectively. The CAGR for the last five years reveals a decrease rate of -2.54% and forecasted growth rates to 2028 aligning with a reduction trend of -12.09%.

Future trends to watch for include potential influences of government policies on pharmaceutical pricing, the impact of global supply chain stability, and increases in production efficiency. Moreover, new regulatory changes and advancements in pharmaceutical technology will likely shape market dynamics in the coming years.